ArticleACS omega2026
Zinc Nanobiohybrid-Catalyzed Hydrolysis of
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, nanotechnology and nanobiohybrid systems have emerged as powerful platforms for applications in biomedicine, biotechnology, and catalytic chemical synthesis. In this study, a novel photocatalytic strategy was developed for the selective hydrolysis of uridine and uridine-derived substrates into uracil using a zinc-based nanobiohybrid catalyst. Different metal-enzyme nanobiohybrids were evaluated as catalysts for the hydrolysis reaction in aqueous media under mild conditions. Among the materials investigated, Zn-BIC, a nanobiohybrid containing highly crystalline Zn nanoparticles of approximately 5 nm that generate nanochannel-like structures, exhibited the highest catalytic performance and selectivity toward uridine hydrolysis. Using 10 mg of catalyst in the presence of 3% v/v H
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.